Growth Metrics

Bio-Techne (TECH) Free Cash Flow Growth (3y) (2012 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Growth (3y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 24.91%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 20.11%
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 14.71%
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -10.65%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 31.42%
10 Bio-Techne 7.92 Bn 7.71 Bn 208.29 Mn 25.99%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 25.99%
Dec 31, 2025 9.49%
Sep 30, 2025 -21.83%
Jun 30, 2025 1.53%
Mar 31, 2025 -18.86%
Dec 31, 2024 -5.14%
Sep 30, 2024 8.90%
Jun 30, 2024 -19.61%
Mar 31, 2024 0.15%
Dec 31, 2023 -4.28%
Sep 30, 2023 -5.97%
Jun 30, 2023 38.32%
Mar 31, 2023 -1.17%
Dec 31, 2022 1.42%
Sep 30, 2022 15.73%
Jun 30, 2022 26.29%
Mar 31, 2022 18.65%
Dec 31, 2021 29.36%
Sep 30, 2021 6.31%
Jun 30, 2021 23.33%
Mar 31, 2021 52.44%
Dec 31, 2020 33.31%
Sep 30, 2020 11.79%
Jun 30, 2020 -15.21%
Mar 31, 2020 24.14%
Dec 31, 2019 12.93%
Sep 30, 2019 7.65%
Jun 30, 2019 9.62%
Mar 31, 2019 0.42%
Dec 31, 2018 7.63%
Sep 30, 2018 11.10%
Jun 30, 2018 25.02%
Mar 31, 2018 -11.14%
Dec 31, 2017 0.27%
Sep 30, 2017 8.56%
Jun 30, 2017 7.89%
Mar 31, 2017 -11.86%
Dec 31, 2016 11.90%
Sep 30, 2016 -5.79%
Jun 30, 2016 10.88%
Mar 31, 2016 8.77%
Dec 31, 2015 13.42%
Sep 30, 2015 -1.31%
Jun 30, 2015 -5.93%
Mar 31, 2015 -7.70%
Dec 31, 2014 21.34%
Sep 30, 2014 -2.59%
Jun 30, 2014 2.36%
Mar 31, 2014 -1.19%
Dec 31, 2013 -1.23%
Sep 30, 2013 -1.00%
Jun 30, 2013 -7.02%
Mar 31, 2013 6.84%
Dec 31, 2012 -4.69%
Sep 30, 2012 -0.88%